The investment landscape is shifting as Jim Cramer’s Charitable Trust announced its entry into a new position with Arm Holdings, acquiring 225 shares at approximately $169 per share. This acquisition represents about 1% of the portfolio and signifies the stock’s promotion from the Bullpen stocks to a watch list. Arm Holdings was added to the Bullpen at the conclusion of the April Monthly Meeting and was discussed in the recent Homestretch report.
Arm Holdings is a key player in the semiconductor ecosystem, specializing in designing high-performance, energy-efficient CPU products and related technology. Unlike traditional manufacturers, Arm has historically focused on designing semiconductors and licensing those designs to major tech firms such as Nvidia, Amazon, and Apple. The relationship between Arm and Nvidia has been particularly noteworthy; Nvidia’s attempted acquisition of Arm for $40 billion in September 2020 ultimately failed due to regulatory hurdles.
Arm’s revenue model primarily relies on licensing fees that customers pay for the use of its intellectual property, alongside royalty fees collected from every chip manufactured using Arm’s designs—typically based on a fixed percentage of the chip’s selling price, with discounts available at higher volumes. Importantly, these royalties are a recurring revenue stream.
Recent developments have marked a significant evolution in Arm’s strategy. During the recent ARM Everywhere event, the company unveiled its first in-house designed central processing unit, the AGI CPU, aimed at handling agentic AI workloads. This pivot from strictly licensing designs to manufacturing its own chips highlights Arm’s ambition to expand its market share amid a landscape dominated by x86 architecture, commonly used by AMD and Intel.
As the AI boom progresses into the so-called agentic phase, the demand for CPUs is increasing. Initially, GPUs were the focus for training large-scale AI models. However, the market has recognized that increased computational tasks necessitate a surge in CPU demand. Arm points out that the current AI data centers require around 30 million CPU cores per gigawatt (GW), a figure set to quadruple as agentic AI applications proliferate. This surge in demand coincides with a CPU shortage, amplifying the urgency for efficient solutions.
Efficient performance is Arm’s selling point. The company asserts that its CPUs offer over double the performance per rack compared to traditional x86 CPUs, potentially saving up to $10 billion in capital expenditures for AI data center capacity. Noteworthy clients such as Meta Platforms and OpenAI have already partnered with Arm, which anticipates more than $1 billion in chip demand in the next two years.
Despite the optimistic outlook for chip sales, Arm faces challenges, particularly related to memory shortages impacting customers’ ability to deploy these chips. The AGI CPU is scheduled to begin shipping by the end of the year. Importantly, Arm’s existing intellectual property business will remain a strong revenue driver, with expectations of 20% compound annual growth in royalty revenue over the next five years.
Looking forward, Arm aims to achieve $25 billion in revenue by fiscal year 2031, with $15 billion coming from in-house chip sales. This projection translates to an earnings-per-share potential of over $9, a substantial increase from the $1.75 EPS forecast for fiscal year 2026.
The investment club has set an initial price target of $200 for Arm’s stock, suggesting a potential upside of approximately 16% from current levels. As this investment aligns with Cramer’s Charitable Trust portfolio, members can anticipate timely trade alerts and strategic insights as they navigate the evolving market landscape.
